Business
HeartBeam to Host Fourth Quarter and Full Year 2021 Results Conference Call on Thursday, March 24, 2022 at 4:30 p.m. Eastern Time
SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine
About this update from Heartbeam, Inc.
[{"type":"text","content":" SANTA CLARA, Calif.--(BUSINESS WIRE)--\nHeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, will hold a conference call on Thursday, March 24, 2022 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full fiscal year ended December 31, 2021, and will be reviewing recent announcements, ongoing initiatives and key 2022 milestones. A press release detailing these results will be issued prior to the call.\n\nHeartBeam CEO and Founder Branislav Vajdic, PhD, CFO Richard Brounstein, and CBO Jon Hunt, PhD, will host the conference call, followed by a question-and-answer period. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the Company’s website here.\n\nTo access the call, please use the following information:\n\n\n\nDate:\n\n\n\n\nThursday, March 24, 2022\n\n\n\n\n\nTime:\n\n\n\n\n4:30 p.m. Eastern time (1:30 p.m. Pacific time)\n\n\n\n\n\nDial-in:\n\n\n\n\n1-877-423-9813\n\n\n\n\n\nInternational Dial-in:\n\n\n\n\n1-201-689-8573\n\n\n\n\n\nConference Code:\n\n\n\n\n13727295\n\n\n\n\n\nWebcast:\n\n\n\n\nhttps://viavid.webcasts.com/starthere.jsp?ei=1530957&tp_key=53b3c7ab88\n\n\n\n\nA telephone replay will be available approximately two hours after the call and will run through June 24, 2022 by dialing 1-844-512-2921 from the U.S., or 1-412-317-6671 from international locations, and entering replay pin number: 13727295. The replay can also be viewed through the webinar webcast link above and the presentation utilized during the call will be available in the company’s investor relations section here.\n\nAbout HeartBeam, Inc.\n\nHeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting at any time and any place. Its breakthrough solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution. No...